10-15 Associates’s Celgene Corp CELG Stock Holding History

10-15 Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,137	Closed	-$2.2M	–	105
2019 Q3	$2.2M	Sell	22,137 -260	-1%	-$24.7K	0.45%	50
2019 Q2	$2.07M	Sell	22,397 -290	-1%	-$27.5K	0.45%	49
2019 Q1	$2.14M	Sell	22,687 -315	-1%	-$27.5K	0.46%	49
2018 Q4	$1.47M	Sell	23,002 -960	-4%	-$70.9K	0.36%	53
2018 Q3	$2.14M	Buy	23,962 +1,180	+5%	+$104K	0.48%	52
2018 Q2	$1.81M	Buy	22,782 +3,680	+19%	+$306K	0.41%	59
2018 Q1	$1.7M	Buy	+19,102	New	+$1.83M	0.4%	55

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

10-15 Associates's CELG Position: Q4 2019 in Review

10-15 Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 22,137 shares — an estimated $2.2M sold.

10-15 Associates first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $2.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

10-15 Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
10-15 Associates sold 22,137 Celgene Corp shares in Q4 2019, an estimated $2.2M.
10-15 Associates first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
10-15 Associates's Celgene Corp position peaked at $2.2M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on 10-15 Associates's 13F filing for Q4 2019, filed 24 Jan 2020.